Moreover, a study reported that the blockade of ActRIIb was able to improve the phenotypic characteristics in the mouse model of DMD [74], as well as the mouse model of amyotrophic lateral sclerosis [75]. The gene discussed is ACVR2B; the disease is Duchenne muscular dystrophy.